Concord Biotech Market Cap

Concord Biotech has a market cap or net worth of 222.76 billion as of December 20, 2024. Its market cap has increased by 58.38% in one year.

Market Cap

222.76B

Enterprise Value

219.96B

Revenue

10.86B

Ranking

n/a

PE Ratio

67.93

Stock Price

2,127.50

Market Cap Chart

Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 222.76B, an increase of 125.85%. That is a compound annual growth rate of 83.47%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	222.76B	44.68%
Dec 29, 2023	153.97B	56.11%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition